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CAVUM SEPTI PELLUCID I IN TOURETTE SYNDROME.
Karen J. Kim and Bradley S. Peterson. Yale Child Study Center, Yale University School
of Medicine, New Haven, CT.

An enlarged cavum septi pellucidi (CSP) has been associated with a variety of
neuropsychiatric disorders and is a putative marker of disturbed brain development. The
goal of this study was to characterize systematically the CSP and the related cavum
vergae in individuals with Tourette Syndrome (TS). The overall size and anteroposterior
length of the CSP in 161 children (97 with TS and 64 normal pediatric controls) and 107
adults (43 with TS and 64 normal adult controls) were rated on high-resolution magnetic
resonance images in the coronal view. The associations of CSP size with diagnosis and
symptom severity scores were assessed using ordinal logistic regression analysis.
CSP size in TS children was significantly smaller than in normal control subjects
and was inversely associated with ADHD symptom severity in the TS subjects. CSP size
was not significantly associated with the comorbid diagnoses of OCD or ADHD. These
results were replicated in an independent sample of TS and normal control adults. The
presence of a cavum vergae was not significantly associated with a diagnosis of TS.
These findings suggest that the pathophysiology of TS may involve abnormalities in the
early development of the CSP or in the neighboring corpus callosum, septal nuclei, or
related portions of the limbic system.
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INTRODUCTION
The cavum septi pellucidi (CSP) is a potential midline space bounded by the two
leaves of the septum pellucidum. The CSP or related cavum vergae (CV) that persist
postnatally are putative markers of disturbances in early brain development (1-3). An
increased size or prevalence of the CSP has been reported in a wide variety of clinical
populations, including children with mental retardation (4) or fetal alcohol syndrome (5),
in individuals with affective disorders (6), and most commonly in patients with
schizophrenia (7, 8).
Tourette Syndrome (TS) is characterized by motor and vocal tics that begin in
childhood and that fluctuate over time. It is frequently associated with other social and
behavioral disturbances (9, 10). In both clinical and epidemiological samples, TS co¬
occurs with Obsessive-Compulsive Disorder (OCD) or Attention-Deficit/Hyperactivity
Disorder (ADHD) (9, 11-14). The co-occurrence of these disorders is thought to be a
consequence of shared genetic and environmental risk factors that produce anatomical
and functional disturbances in cortical-subcortical circuitry (15, 16). Pre- and perinatal
risk factors such as maternal stress, low birth weight, and obstetric complications
associated with CNS hypoxia or ischemia have been hypothesized in TS to play a role in
modulating both symptom severity and the likelihood of having comorbid OCD or
ADHD (17-20). The anatomical connectivity of the septal region that surrounds the CSP
is intimately related to this cortical-subcortical circuitry. Characterizing the septal region
may therefore provide important information in these patient populations concerning
disturbances in the anatomical and functional development of these circuits. Isolated case
reports have suggested that the CSP may be enlarged in tic disorders (21-23).

?

STATEMENT OF PURPOSE
The main objective of our study was to characterize the occurrence and size of
CSP in individuals with TS. We hypothesized that the CSP differs significantly in size in
subjects with TS compared to normal controls. The presence of CSP and CV was
evaluated in MRI scans from 140 individuals with TS and 128 normal control subjects.
In addition, correlations of CSP size with the severity of tic, OCD, and ADHD symptoms
were examined in the patient group.
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METHODS
Subject Recruitment and Characterization
Subjects with TS (97 children and 43 adults) were recruited from the Tic and
Obsessive-Compulsive Disorders Specialty Clinic at the Yale Child Study Center.
Normal controls (64 children and 64 adults) were recruited from a list of families in the
local community purchased from a telemarketing company. These individuals were
identified as being within a specified age range and as living in the same neighborhoods
(based on zip code) as the TS subjects. Individuals from the list were randomly selected
for contact. Introductory letters were sent and followed by screening phone calls. Of the
eligible control subjects contacted, approximately 10% participated. After complete
description of the study to the subjects, written informed consent was obtained. Each
child subject’s assent was also obtained.
Subjects were aged 5 to 63 years, and they were predominantly right-handed (24).
Subjects included individuals with a primary diagnosis of TS with or without comorbid
OCD or ADHD, and normal controls. A DSM-IV diagnosis of TS was based on an
extensive clinical examination (B. Peterson and L. Scahill). Comorbid neuropsychiatric
diagnoses were established through administration of the Schedule for Tourette
Syndrome and Other Behavioral Disorders (STOBS) (25), a structured interview which
includes the Kiddie-Schedule for Affective Disorders and Schizophrenia Epidemiologic
Version, the adult Schedule for Affective Disorders and Schizophrenia (26, 27), and more
detailed sections on TS and OCD for both children and adults (28). Exclusionary criteria
for TS subjects included another movement disorder or a major psychiatric disorder other
than OCD or ADHD that antedated the onset of tics. For all control subjects,
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exclusionary criteria included any history of tic disorder, OCD, ADHD, or current Axis I
disorder. Additional exclusionary criteria for both groups included a history of seizure or
head trauma with loss of consciousness, ongoing substance abuse or previous substance
dependence, or IQ below 80.
At the time of the study, 59 child TS subjects (61%) were taking psychotropic
medication that included typical neuroleptics (n= 15), atypical neuroleptics (n=3),
stimulants (n=4), alpha-agonists (n=21), serotonin-specific reuptake inhibitors (n=8), or
tricyclic antidepressants (n=7). Of the adult TS subjects, 27 (63%) were taking
medication, which included typical neuroleptics (n=3), atypical neuroleptics (n=l), alphaagonists (n=4), serotonin-specific reuptake inhibitors (n=9), or tricyclic antidepressants
(n=l).
Ratings of current (at the time of scan) and worst-ever severity of tic and OCD
symptoms were obtained using the Yale Global Tic Severity Scale (29) and either the
adult or child version of the Yale-Brown Obsessive Compulsive Scale (30, 31). The
Child Behavior Checklist (CBCL) (32) and the Conners Parent and Teacher Rating Scales
(33) scores were obtained for subjects under 18 years of age. Ratings of ADHD symptom
severity both at the time of scanning and prior to initiating medication were obtained
using the ADHD rating scale (34). Socioeconomic status at birth was estimated using the
Hollingshead Four-Factor Index of Social Status (35).

MRI Scanning
Magnetic resonance images (MRI’s) of the brain were obtained using a single GE
Signa 1.5-Tesla scanner (General Electric, Milwaukee, WI). Head position was
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standardized using canthomeatal landmarks. A 3-dimensional-spoiled gradient recall
sequence was obtained for analyses of the CSP and CV (repetition time, 24 milliseconds;
echo time, 5 milliseconds; flip angle, 45 degrees; frequency encoding superior/inferior;
no wrap; 256x192 matrix; field of view, 30 cm; 2 excitations; slice thickness, 1.2mm; and
124 contiguous slices encoded for sagittal slice reconstructions).

CSP Measures
MRI’s were analyzed on Sun Ultra 10 workstations using ANALYZE 7.5
software (Biomedical Imaging Resource, Mayo Foundation, Rochester, MN; Richard A.
Robb, Ph.D., Director). Scans were cropped and magnified 12-fold in each dimension to
aid in coding of the CSP. The same observer (K.K.) rated all scans blind to diagnosis and
subject characteristics.
Ratings of Coronal Grade. Scans were rated in the coronal view, and the CSP

was graded on an ordinal scale of 0 to 4, with descriptive anchors based on the overall
size of the visible cavity (0 = absent; 1 = questionable/equivocal; 2 = mild CSP; 3 =
moderate CSP; 4 = large CSP). Ratings conformed with previously published methods
(36-38) and were performed on the coronal slice that showed the greatest evidence of a
cavity. A rating of 0 was assigned if an intact septum pellucidum was clearly visible in
all slices (ie. no CSP was present), a rating of 1 was assigned if the septum was unclear
(ie. questionable CSP), and ratings from 2 to 4 were assigned based on size of the visible
cavity (ie. based on the area, height, and width of the cavity in the coronal view).
Reliability of the ratings was aided by comparison with a set of standard CSP images
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Figure 1: Images of representative cava septi pellucidi. Each subjects' brain MRI scan was
graded on a scale of zero to four based on presence and size of the CSP. A rating of grade 0 was
assigned if there was an intact septum pellucidum. grade 1= questionable CSP, grade 2^mild
CSP, grade 3= medium CSP, grade 4= large CSP.

Cavum Septi Pellucidi

Grade 0

Grade 1

Grade 2

Grade 3

Grade 4
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from each ordinal grade (see Fig.l). Reliability was quantified using CSP ratings
obtained independently from 30 randomly selected scans by two raters familiar with CSP
anatomy. Inter-rater reliability was excellent (weighted k=0.72) (39, 40). The presence of
a CV, a potential caudal extension of the CSP (41), was similarly assessed in each scan.
Ratings of CSP Length. The anteroposterior length of the CSP was measured by

counting the number of coronal slices containing evidence of the CSP according to
previously described methods (42): 0 = absent, 1 = CSP seen in 1 slice only, 2 = CSP
seen in 2 slices, etc. The number of coronal slices was multiplied by the width of each
image slice to obtain the anteroposterior length of the CSP in millimeters. Reliability
between two raters for these length measurements yielded moderate agreement (weighted

k=0.56).

Statistical Analyses
All statistical procedures were performed using SPSS for Windows version 10.0
(Statistical Product and Service Solutions Inc, Chicago, EL). All p-values were of the 2sided type.
Ratings of CSP size. We tested our primary null hypothesis (that CSP size was not

associated with the diagnosis of TS) using ordinal logistic regression with a logit link.
Hypothesis testing was performed using the CSP grade primarily, and secondary testing
was done with CSP length. Regression analyses were performed first in children (<18
years) and then in an independent sample of adults (18-64 years) in an attempt to replicate
findings from the children.
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Ordinal ratings of CSP grade were the dependent measure in ordinal regression
analyses. The diagnosis of TS was included as the between-subjects factors, and lifetime
diagnoses of OCD or ADHD, age, sex, SES at birth, and whole brain volume (WBV)
measurements were included as covariates. WBV measurements were included to control
for generalized scaling effects within the brain (43). Although handedness and minority
status were initially included as possible confounding factors, they were found to have
negligible effects on the parameter estimates. Consequently, neither was included in the
final models. The same set of regression analyses was then performed entering CSP
length as the ordinal dependent measure.
In addition to the above covariates, 2-way and 3-way interactions between
diagnosis and covariates were considered for inclusion in the models. Terms that were
not significant were eliminated via backward stepwise regression, with the constraint that
the model at each step was hierarchically well-formulated (ie. all possible lower order
terms must be included in the model regardless of their significance) (44, 45). Two-way
interactions between TS and medication use were also entered into the regression model
to assess possible medication effects. No interactions were found to be significant, so
none were included in the final models.
For each of the continuous covariates (age, SES, WBV), the proportional odds
assumption was graphically checked by plotting the cumulative logits of dichotomized
ordinal ratings against each covariate (46). Each plot confirmed that the dichotomized
responses were linearly related to the covariates, validating use of the ordinal regression
modeling for the analyses.
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Associations of CSP grade with symptom severity. Symptom severity ratings were

available for the majority of TS subjects. Children and adults with TS were combined for
these analyses. The associations of CSP grade with the severity of current and worst-ever
tic and OCD symptoms, premedicated and current ADHD symptoms, Conners parent and
teacher scores, and CBCL scores were explored. Correlations of symptom severity with
CSP grade were performed using ordinal regression analysis with CSP grade as the
dependent variable, sex as a between-subjects factor, and symptom severity as a
continuous covariate. Age and WBV were also entered as covariates.

{Note: The recruitment and characterization of the subjects (the structured diagnostic

interviews and symptom severity ratings), and the collection of raw MRI scans for this
study were performed by other members of the Peterson lab team over the last ten years
as part of prior ongoing studies. Review of the existing literature, subsequent
development of CSP measures and reliability testing, rating of the 268 MRI scans, CSP
data collection and entry, evaluation of medication effects and all statistical analyses were
performed exclusively by K. Kim.)
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RESULTS
Subjects
High-resolution anatomical brain MRI scans were acquired in 161 children (97 TS
subjects and 64 normal controls) and 107 adults (43 TS subjects and 64 normal controls).
Amongst the children with TS, 30 (31%) of these subjects also carried lifetime diagnoses
of OCD and 29 (30%) had diagnoses of ADHD. In the TS adults, 23 subjects (53%) also
had lifetime diagnoses of OCD and 7 (16%) had ADHD.
Amongst the children, the patient group was slightly older than the control group
(11.2 ± 2.3 vs. 10.1 ± 2.2 (mean ± SD),

= 2.76, p = .06) and had a higher proportion

659

of males (79.4% vs. 54.7%, X - 11.1, p < .001), but both groups were comparable in
terms of SES (p - .38). In the adult population, the control group had a higher SES (48.5
± 9.8 vs. 43.6 ± 11.1,1105 = -2.40, p < .02) than the TS group, but they were similarly aged
(p = .16) and had similar proportions of males (p = .96).

Hypothesis Testing
In analysis of the children only, a diagnosis of TS was a significant predictor of
CSP grade in children (p < .03, see Table la), allowing rejection of our null hypothesis
that CSP size was unrelated to diagnosis of TS. The parameter estimate for a diagnosis of
TS (PE = -0.77) indicated that these subjects had smaller CSPs than did the control group
(see Fig.2a). The covariates of OCD and ADHD were not found to be significant,
suggesting that the association of TS with CSP grade was not due to the presence of
comorbid OCD or ADHD. WBV was included as a covariate to account for scaling
effects, and was associated with CSP grade only at a trend level of significance (PE =
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2.71E"06, p = .07). Socioeconomic status, age, and sex were not associated with CSP
grade, and did not interact significantly with a diagnosis of TS. Interactions between TS
diagnosis and psychotropic medication use, specifically neuroleptic use, were not
significant (TS*any medication: PE = .02, p = .98; TS*neuroleptic: PE = .17, p = .73),
indicating that medication use did not significantly contribute to our finding of smaller
CSPs in the patient group.
Findings were similar when CSP length was entered as the ordinal dependent
measure in our regression analyses (see Table lb). CSP length tended to be shorter in the
TS children (PE = -.64, p < .06) compared to healthy subjects. No covariates or
interactions were associated significantly with CSP length.

Replication in Adults
In adults, a diagnosis of TS was found to be a significant predictor of CSP grade
(p < .05) and CSP length (p < .01) (Table la-b). As in the child population, the CSPs in
TS adults were smaller and shorter than in control adults (Fig.2b) (CSP grade: PE = -1.05,
CSP length: PE = -1.40). Interactions between diagnoses and covariates were not
significant and therefore not included in the final model. WBV was the only significant
covariate in the CSP grade regression model (PE = 3.68E-6, p < .05), accounting for
scaling effects. Age was a significant covariate in the CSP length regression model (PE =
.04, p < .04). No significant interactions of TS with neuroleptic or other medication use
were detected.
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Children
Source
TS
OCD
ADHD
Age
Sex
SES
WBV

PE
-.77
-.30
-.40
-.04
.68
.02

OR
.17
.51
.40
.91
4.76
1.05

2.71E-6

1.00

Adults

SE P-value
.35
<.03
.41
.48
.41
.33
.07
.55
.38
.08
.01
<.001

PE
-1.05
.85
-.76
.02

.18

.11

-.02

.07

3.68E-6

OR
.09
7.06
.18
1.05
1.53
.95
1.00

SE P-value
.54
<.05
.59
.15
.81
.35
.02
.23
.47
.70
.02
.26
<.001
<.05

Table la: CSP Ordinal Regression Model for CSP Grade. Ordinal logistic regression
analysis was used to assess whether diagnosis of TS was a significant predictor of CSP grade in
children and adults. Diagnoses of comorbid OCD and ADHD, age, sex and SES were entered as
covariates. WBV was also included as a covariate to account for scaling effects. CSP grade was
signficantly associated with a diagnosis of TS in both children and adults. Diagnoses of
comorbid OCD and ADHD, age, sex and SES were not significantly associated with CSP grade.
WBV was significantly associated with CSP grade in the adult model. PE=parameter estimate,
OR=odds ratio, TS=Tourette Syndrome, OCD=Obsessive-Compulsive Disorder, ADHD=
Attention Deficit Hyperactivity Disorder, SES=socioeconomic status at birth, WBV=whole brain
volume.

Source
TS
OCD
ADHD
Age
Sex
SES
WBV

PE

OR

-.64
-.03
-.15
-.04
.58
.02

.23
.92
.71
.92
3.81
1.04

2.62E-6

1.00

Children
SE P-value
.34
.40
.39
.06
.37

<.06
.93
.71
.55

.01
<.001

.23
.07

.11

PE

OR

-1.40
.84
-.78
.04
.53
-.03
2.45E-6

.04
6.91
.17
1.08
3.40
.94
1.00

Adults
SE P-value
.54
.59
.81
.02
.47
.02
<.001

<.01
.15
.34
<.04
.25
.19
.18

Table lb: CSP Ordinal Regression Model for CSP Length. Estimated CSP length was
associated with a diagnosis of TS in both children and adults. Diagnosis of comorbid OCD and
ADHD, sex, SES and WBV were not significantly associated with CSP length. Age was
significantly associated with CSP length in the adult model only. Abbreviations are as in Table
la.
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Figure 2: Frequency Distributions of CSP Grade in patients and normal controls. These
plots display the number of TS patients versus control subjects rated in each ordinal category of
CSP grade. The control subjects are distributed approximately normally between grades 0 and 4,
while the patients' grades are shifted to the left. TS = Tourette Syndrome.

2a. Children
35 T

CSP Grade

2b. Adults

CSP Grade
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Associations with Symptom Severity
In TS children and adults, CSP grade was significantly associated with the pre¬
medicated severity scores for ADHD inattention and combined-type symptoms
(inattention: PE = -.12, p < .002, N = 64; combined-type: PE = -.06 , p < .003, N = 64).
For subjects with TS, including those with comorbid OCD or ADEID, having a smaller
CSP was associated with more severe premedicated ADHD symptoms. CSP grade was
not significantly associated with the severities of current ADHD symptoms, nor with tic
or OCD symptoms.

Additional Characterization of the CSP and CV
In the children, 30 patients (31%) and 10 normal controls (16%) had no CSP (ie.
Grade 0), while 44 patients (51%) and 43 normal controls (67%) had mild, moderate, or
large CSPs (ie. grades 2-4). One child with TS and ADHD had a CSP of grade 4 with a
CV. In the adult population, 9 TS (21%) and 10 normal controls (16%) had no CSP,
while 16 TS subjects (37%) and 38 normal controls (59%) had CSPs of grade 2-4. Two
of the adult normal controls and one TS subject with OCD had a CSP of grade 4 with a
CV. The presence of a CV was not significantly associated with a diagnosis of TS
(Fisher’s p = 1.0 for children and adults).
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DISCUSSION
The aims of this study were to characterize the CSP in TS subjects and to assess
whether symptom severity was related to CSP size. We found that the CSP in TS
children was smaller than in normal control children, using both CSP grade and estimated
CSP length as indicators of CSP size. We then replicated these findings in an
independent sample of TS and normal adult subjects. CSP grade and length were not
significantly associated with a lifetime diagnosis of comorbid OCD or ADHD, sex, or
socioeconomic status. Age was only significantly associated with CSP length in the adult
group. Neuroleptic or other psychotropic medication use did not seem to contribute to the
finding of smaller CSPs in TS subjects.
CSP grade was also significantly related to the severity of ADHD inattention and
combined-type symptoms in TS subjects prior to beginning medications. CSP grade was
not associated, however, with the severity of current ADHD symptoms, tic, or OCD
symptoms.
In addition to the findings in TS subjects, this study provides normative data on
CSP size in a large, community-based sample of healthy children and adults. Previous
prevalence estimates in normal adults has ranged widely from 2% to 85% (8, 36, 41,47,
48). This variability in previous prevalence estimates has several likely sources. First,
most prior studies regarded the CSP dichotomously as either “enlarged” (and
pathological) or “within normal limits,” and the criteria for this rating varied considerably
across studies. Second, most prior studies have been either postmortem investigations, in
which fixation procedures can alter CSP morphology, or lower resolution imaging studies
that could underestimate the prevalence of small CSPs. Third, prior studies have drawn
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subjects from heterogeneous clinical populations, where CSPs tend to be larger and more
variable (49). In contrast, the present study employed measures from high-resolution
scans obtained in a large community sample of healthy subjects. These methodological
advantages are probably why the data from this sample were able to reveal that CSP size
in the general population is likely to be continuous and normally distributed (Fig.2). The
underlying normal distribution of CSP size is presumably a direct consequence of normal
variability in CSP closure during early development. In addition, our results suggest that
the distribution of CSP sizes is similar in children and adults (50, 51), consistent with the
determination of CSP size early in development.

Embryology of the Septal Region
The embryology of the CSP and the associated septal region is relevant to
understanding the significance of these findings for the pathophysiology of TS. The CSP
first appears in week 12 of gestation. It begins as a hollowing of the solid lamina
terminalis beneath the primordial hippocampal tissue. Initially, differential growth of the
neighboring corpus callosum is thought to stretch and progressively thin the lamina
terminalis to form a clear membrane, the septum pellucidum. Continued growth of the
corpus callosum further stretches the septum pellucidum to produce a midline cleavage
(47, 49, 52, 53) (see Fig.3a-b). Invasion of circulating phagocytic monocytes may help to
cavitate the septum to create the CSP (54, 55). The leaves of the septum pellucidum now
laterally bound the CSP on each side.
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Figure 3: CSP embryology and development.
3a. Development of the corpus callosum and cavum septi pellucidi (coronal view).
i) Juxtaposition of the banks of the median sulcus, and formation of the massa commissuralis in
the region of the primordial hippocampus (PriHp) in the floor of the interhemispheric fissure, ii)
The commissuration of the hemispheres by fibers of the corpus callosum (CC) and rostral
extension of the massa commissuralis over the median sulcus, iii) Separation of the banks of the
median sulcus forming the leaves of the septum pellucidum (SP). The CSP is sealed inferiorly
by the rostrum of the corpus callosum. Fo=fomix, Iso=isocortex, SA=septal area,
GE=ganglionic eminence. (53)

u.
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3b. Phylogenetic development of the septal region (sagittal view). Development of
the CSP in humans roughly recapitulates phylogenetic development, i) Marsupials: The
hippocampus (Hp) and subiculum (su) are dorsal to the lamina terminalis (LT). ii) Intermediate
stage: The hippocampus begins to infold, iii) Hedgehog and bat: The corpus callosum (cc) and
fornix (Fo) have broken through the subiculum. iv and v) Rat: The intercommissural
hippocampus has been obliterated, leaving only the pre- and post-commissural parts, vi)
Humans: The corpus callosum grows lengthwise in the direction of the arrows, and the septum
pellucidum (SP) stretches anteriorly. PHp=precommissural hippocampus, AC=anterior
commissure, Rcc=rostrum of CC, Scc=splenium of CC, Gcc=genu of CC. (49)

At approximately the 20th week of gestation, the leaves of the septum pellucidum
fuse in the posterior to anterior direction, probably as a consequence of continued growth
of the anterior portion of the corpus callosum and hippocampal alvei (3, 41). Growth of
the rostrum of the corpus callosum apposes the inferior aspect of the two leaves of the
septum pellucidum and subsequently seals the CSP inferiorly. Cells migrating inward
from the lateral septal nuclei then populate the CSP (54, 55). CSP closure reaches its

19

adult state in the majority of children by 6 months of age (1). Whether structural
plasticity in the surrounding septal tissue can alter CSP morphology subsequently in
development is unknown.
The formation and resolution of the CSP is therefore intimately linked with
concurrent development of the corpus callosum, hippocampus, amygdala, and septal
nuclei. Disturbances of CSP anatomy in children and adults could thereby reflect
embryological abnormalities in the development of these neighboring structures. Given
the possible relevance of these multiple neighboring regions in determining CSP
morphology, focusing solely on either the CSP in the coronal view or on its
anteroposterior length (as many previous studies have done) may offer an incomplete
view of CSP pathology. The degree of non-closure of the CSP in the lateral and superiorinferior dimensions (ie. the width or height of the cavity) along with its anteroposterior
length may jointly provide important clues to altered CNS development.

Septal Anatomy and Function
The septal region is an important component of the limbic system that has
widespread connections to other regulatory centers in the brain (see Fig.4). It serves as a
key relay station between the hypothalamus, hippocampus, amygdala, and brainstem (56).
These septal circuits are thought to play an important role in numerous biological and
behavioral systems, including self-maintenance, sensory processing, attention and
activity, memory and learning, sexuality, aggression, homeostasis, emotionality, and
maternal behavior (3, 57-59). Abnormal development of the septal region therefore may
disrupt one or more of these functions.
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Figure 4: Anatomy of the septal region. The septal nuclei are located inferolateral to the
septum pellucidum. These nuclei, part of the limbic system, relay fibers between the brain stem,
hippocampus, amygdala, habenula, hypothalamus, mamillary bodies, substantia nigra, cingulate
gyrus, forebrain, and cortex. The medial septal nuclei are primarily output nuclei and include the
nucleus of the diagonal band of Broca, the bed nucleus of the stria terminalis, the bed nucleus of
the anterior commissure, and the septofimbrial nucleus. The lateral septal nuclei are primarily
input nuclei and include the nucleus basalis of Meynert and the nucleus accumbens (56). The
brain is represented here in a coronal view. CA=caudate nucleus, PU=putamen, SP=septum
pellucidum, SN=septal nuclei, NDB=nucleus of the diagonal band of Broca, CC=body of the
corpus callosum, NA=nucleus accumbens, SI=substantia innominata, AON=anterior olfactory
nucleus, SG=subcallosal gyrus, IC=internal capsule, LV=lateral ventricle, frontal horn. (60)

The septal nuclei and related limbic system circuits are interconnected with many
of the brain regions implicated in the pathophysiology of TS-related disorders (15). The
sexual and aggressive content of many tics, obsessions, and compulsions, for example,
suggests involvement of these systems in TS and OCD. The septal nuclei are thought to
help filter sensory input, and lesions in this region have resulted in increased motoric
activity and hyperreactivity to stimuli (59, 61, 62). Related limbic circuits could thereby
contribute to the attentional and motor abnormalities in TS and ADHD. The regions with
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the strongest anatomical connections to the septal nuclei, such as the cingulate cortex,
temporal lobe, hypothalamus, and periaqueductal gray, are limbic system components that
have previously been hypothesized to contribute to the appearance and modulation of TSrelated symptoms (63-67).

Pathophysiology
The finding of smaller CSPs in a patient population has not been reported
previously. It highlights the importance of considering the role of the developing CSP
and associated septal nuclei in the pathogenesis of TS. A smaller CSP in TS patients
could arise from disturbances in the formation of the CSP, from excessive or premature
closure of the CSP, or as a consequence of potential postnatal plastic changes in septal
tissue surrounding the CSP. The timing of these developmental abnormalities, whether
early or late in life, are key to determining what role the altered CSP morphology might
play in the pathophysiology of TS.
The embryological origins of the CSP suggest that smaller CSPs could be a
consequence of an initial failure of the corpus callosum to develop properly during
gestation. It may therefore be relevant that abnormalities in corpus callosum morphology
have been reported in both TS children and adults (68, 69). Alternatively, smaller CSPs
could arise secondary to a genetic or environmental event during the pre- or perinatal
period that exaggerates CSP closure. Peri- or postnatal plastic changes in the septal area
that preferentially affect TS subjects could also produce localized septal hypertrophy and
therefore smaller CSPs (43). Similarly, hypertrophy of neighboring structures potentially
involved in TS pathophysiology (such as the thalamus or hypothalamus) could contribute
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to increased closure rates for the CSP. Finally, postnatal fibrosis and gliosis in the septal
region, perhaps a consequence of autoimmune processes that have been suspected in
some cases of TS (70, 71), could produce CSP narrowing.
The pathophysiological relevance of the association of CSP grade with the
severity of premedicated ADHD symptoms in TS subjects is unclear. CSP size may
reflect alterations in septal tissue or related brain regions that help modulate the severity
of ADHD symptoms. The association therefore suggests that early developmental events
may contribute to ADHD comorbidity in TS subjects. Because ADHD (unlike OCD) is
unlikely to be a variant expression of an underlying TS genetic diathesis (14, 72), these
early developmental events that influence ADHD comorbidity in TS seem likely to be of
a nongenetic origin. CSP size may also be associated nonspecifically with ADHD
symptom severity (ie. regardless of the presence of tics). The group specificity of these
associations therefore requires further study in larger samples of OCD and ADHD
subjects.

Limitations and Future Directions
This study points to the likely importance of early developmental events in the
pathophysiology of TS. Future studies will need to focus on these early events to
determine which pre- and peri-natal complications might affect both the size of the CSP
and the course of illness. Our findings suggest that the limbic system may be an
increasingly important, though heretofore relatively neglected, area of TS research. The
CSP, however, offers only an indirect assessment of the development of the septal region
and its associated limbic structures. More detailed morphometric and functional imaging
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studies as well as postmortem examinations are needed to define better the sequelae of
disturbances in septal and limbic system development in TS. Studies of the nucleus
accumbens, hippocampus, amygdala, cingulate, hypothalamus, and brain stem nuclei may
therefore be informative in TS research, as they all have strong connections to the septal
nuclei. They would complement the current findings and further elucidate the role of the
limbic system in the pathophysiology of TS.
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